STAT3 and ovarian carcinoma: Treatments with Wnt, Notch or STAT3 selective inhibitor reveal that only AG490, a JAK-specific inhibitor, inhibits OVCAR-3 and CAOV-3 cells in the extent as similar as that of resveratrol, suggesting the importance of STAT3 activation in the maintenance and survival of ovarian cancer cells.